Few studies examine how severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) tests assist or hinder efforts to prevent illness, hospitalisations, or people dying. Due to weak evidence, we’re ...
Revvity said on Thursday that it has partnered with French drugmaker Sanofi on the development of a test for the early detection of type 1 diabetes (T1D). Revvity currently offers a research-use-only ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback